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Glutamate uptake, mediated by electrogenic glutamate transporters largely localized
in astrocytes, is responsible for the clearance of glutamate released during excitatory
synaptic transmission. Glutamate uptake also determines the availability of glutamate
for extrasynaptic glutamate receptors. The efficiency of glutamate uptake is commonly
estimated from the amplitude of transporter current recorded in astrocytes. We
recorded currents in voltage-clamped hippocampal CA1 stratum radiatum astrocytes
in rat hippocampal slices induced by electrical stimulation of the Schaffer collaterals.
A Ba2+-sensitive K+ current mediated by inward rectifying potassium channels (Kir)
accompanied the transporter current. Surprisingly, Ba2+ not only suppressed the K+
current and changed holding current (presumably, mediated by Kir) but also increased the
transporter current at lower concentrations. However, Ba2+ did not significantly increase
the uptake of aspartate in cultured astrocytes, suggesting that increase in the amplitude
of the transporter current does not always reflect changes in glutamate uptake.
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INTRODUCTION
Glutamate is the major excitatory neurotransmitter in the brain.
After synaptic release, this neurotransmitter is quickly cleared by
diffusion and uptake (Bergles and Jahr, 1998). Uptake is medi-
ated by glutamate transporters powered by the transmembrane
K+ and Na+ gradients. Glutamate transporters belong to sev-
eral groups (EAAT1-5) and are expressed in both neurons and
astrocytes. In addition to uptake, these transporters are involved
in buffering (Diamond and Jahr, 1997) and release of gluta-
mate in a process termed “reversed uptake” (Rossi et al., 2000;
Grewer et al., 2008). All of these processes shape the glutamate
concentration profile in the synaptic cleft, regulate activation of
high-affinity extrasynaptic glutamate receptors, and play a cru-
cial role in spillover and intersynaptic crosstalk (Kullmann and
Asztely, 1998; Bergles et al., 1999; Diamond, 2001; Zheng et al.,
2008). Efficient glutamate transporters also separate the synap-
tic and extrasynaptic signaling pathways by “shielding” synapses
from extrasynaptic glutamate (Lozovaya et al., 2004; Wu et al.,
2012). Failure to remove glutamate after synaptic release, as well
as activation of reversed uptake (e.g., under ischemic condi-
tions) can lead to glutamate accumulation in the extracellular
space, leading to uncontrolled excitation, epileptiform discharges,
and eventually neuronal death (glutamate cytotoxicity), which is
linked to severe neurodegenerative diseases (During and Spencer,
1993; Schousboe and Waagepetersen, 2005).
Although both neurons and astrocytes express glutamate
transporters, the uptake capacity of astrocytes is much higher
than that of neurons (Rothstein et al., 1996; Danbolt, 2001).
Deficiencies of astrocytic glutamate uptake are directly implicated
in the pathogenesis of several neurologic disorders, such as amy-
otrophic lateral sclerosis (Rothstein et al., 1992), Alzheimer’s
disease (Masliah et al., 1996), Parkinson’s disease (Blandini et al.,
1996), and epilepsy (Meldrum, 1994). Reduced transporter activ-
ity is also reported in the hippocampi of patients with pharmaco-
resistant epilepsy, which comprise up to 1/3 of all epilepsy patients
(Regesta and Tanganelli, 1999; Proper et al., 2002).
Because glutamate transport is electrogenic, the efficiency of
astrocytic glutamate transporters is commonly estimated by mea-
suring the transporter current evoked in voltage-clamped astro-
cytes by synaptic stimulation (Bergles and Jahr, 1997; Diamond
and Jahr, 2000; Tanaka et al., 2013). Another major component
of astrocytic current is mediated by inward rectifying potassium
channels (Kir) (Kofuji and Newman, 2004). This component is
sensitive to Ba2+. Here, we found that Ba2+ also increases the
amplitude of glutamate transporter current but does not affect
aspartate uptake by these transporters in hippocampal astrocytes.
METHODS
PREPARATION AND MAINTENANCE OF SLICES
Sprague Dawley rats (postnatal days 21–28) were anesthetized
with halothane prior to decapitation. Hippocampi were dissected
and 400-µm transverse hippocampal slices were cut using a VT
3000 vibratome (Leica, Wetzlar, Germany) in ice-cold cutting
solution containing (in mM): 50 sucrose, 87 NaCl, 3 KCl, 0.5
CaCl2, 25 NaHCO3, 1 NaH2PO4, 7 MgCl2, and 25 D-glucose.
Slices were allowed to recover at 36◦C for 1 h in storage solution
containing (in mM): 124 NaCl, 3 KCl, 1 CaCl2, 25 NaHCO3, 1
NaH2PO4, 3 MgCl2, and 25 D-glucose (gassed with 95% O2 and
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5% CO2, pH 7.4). One slice was then placed in a submerged-type
recording chamber (volume, ∼2ml) and continuously perfused
at 2ml/min and at 34◦C during the experiments with normal
physiologic solution containing (in mM): 124 NaCl, 3 KCl, 2
CaCl2, 25 NaHCO3, 2 MgCl2, and 10 D-glucose.
ELECTROPHYSIOLOGY
Whole-cell patch-clamp recordings were performed in visual-
ized astrocytes using an EPC 10 amplifier (HEKA Elektronik,
Germany) or Multiclamp 700B amplifier (Molecular Devices,
USA). The patch pipette solution contained (in mM): 125
K-gluconate, 19 KCl, 10 NaCl, 2 Mg-ATP, 0.3 EGTA, 0.5 Na-GTP,
10 phosphocreatine, and 10 HEPES, and the pH was adjusted to
7.3 with KOH. Patch pipettes were fabricated from borosilicate
glass (Harvard Apparatus, UK), with resistance ranging from 6 to
8M. For recordings of synaptically-induced astrocytic current,
50µMDL-2-amino-5-phosphonovalerate (DL-APV) and 10µM
6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; Sigma-Aldrich,
USA) were added to the solution. In experiments with caged
MNI-glutamate, 0.5µM tetrodotoxin (Tocris Bioscience, USA)
was also added. In one set of experiments, we used a Cs-based
intracellular solution containing (in mM): 125 Cs-gluconate, 19
CsCl, 2 Mg-ATP, 5 BAPTA, 0.5 Na-GTP, and 10 HEPES (pH
adjusted to 7.3 with CsOH).
LOCAL PHOTOLYSIS OF CAGED GLUTAMATE
Glutamate was locally photolyzed from the cagedMNI-glutamate
(Sigma-Aldrich) as described previously (Khirug et al., 2005).
Caged MNI-glutamate (2mM) was dissolved in the physio-
logic solution and delivered at a flow rate of 1µl/min to the
vicinity of the patch-clamped cell using an UltraMicroPump
II syringe pump (WPI, USA) and a syringe tip with an
inner diameter of 100µm. Local photolysis of caged MNI-
glutamate was performed with laser light (375 nm, Oxxius,
France) through an Olympus LUMPlanFl 60× water-immersion
objective. The beam yielded an uncaging spot of ∼10µm in
diameter that was focused at the soma. The laser power (1–5mW
at the objective output) and flash duration (10–20ms) were
set at a level that provided a good signal-to-noise ratio for
uncaging-evoked currents. Control experiments showed that the
laser flash evoked no responses in the absence of the caged
glutamate.
ASTROCYTE CULTURE
Primary cortical astrocyte cultures were prepared from the cere-
bral cortex of P2 Wistar rats. Cells were dissociated with mechan-
ical trituration and papain in a Ca2+- and Mg2+-free balanced
salt solution (HBSS, pH 7.4), supplemented with 1mM sodium
pyruvate and HEPES. After centrifugation at 1000 rpm for 5min,
the cells were suspended in high-glucose Dulbecco’s modified
Eagle’s medium (DMEM; Lonza, Switzerland) supplemented with
10% fetal bovine serum and 25µg/mL penicillin/streptomycin.
Astrocytes were plated at a density 30 × 103 cells/cm2 on 6-well
Corning Costar cell culture plates, pre-treated with poly-L-lysine
(1–2µg/cm2). Cells were grown in 5% CO2/95% air atmosphere
at 37◦C. The day of plating was designated as day-in-vitro 0
(DIV0). Medium was changed every 3–4 days.
UPTAKE ASSAY IN CULTURED ASTROCYTES
A modification of a previously described method (Kimelberg
et al., 1990) was used to investigate aspartate uptake in cultured
astrocytes. All steps were performed at room temperature,
unless otherwise specified. Astrocytes (23–25 days in vitro)
growing on 6-well plates were washed once with warm uptake
buffer and then pre-incubated in 1ml/well of uptake buffer
for 15min at 37◦C and 5% CO2. The uptake buffer con-
tained (in mM): 135 NaCl, 5 KCl, 2.5 CaCl2, 0.6 MgCl2, 6
D-glucose, and 10 HEPES, and the pH was adjusted to 7.40
with NaOH. Subsequently, uptake was initiated by replacing
the pre-incubation buffer with 1ml/well of uptake buffer con-
taining the substrate [20µM D-aspartic acid (Sigma-Aldrich),
1% of which was D-[2,3-3H]-aspartic acid (PerkinElmer;
10.0 Ci/mmol)] either alone or in combination with 1µM
of BaCl2 (Sigma-Aldrich) or 2µM of the EAAT1/2 inhibitor
(3S)-[[3-[[4-(trifluoromethyl)benzoyl]amino]phenyl]methoxy]-
L-aspartic acid (TFB-TBOA; Tocris Bioscience). Uptake was
continued for 20min at 37◦C and 5% CO2 and then terminated
by placing the cells on ice and washing rapidly three times
with ice-cold 0.32M sucrose. The cells were then immediately
solubilized in 0.25MNaOH (1ml/well). The amount of aspartate
retained by the cells was determined by measuring the radioac-
tivity of the solubilized samples by scintillation counting using
a Wallac WinSpectral 1414 liquid scintillation counter after
adding Optiphase HiSafe 3 scintillation cocktail (PerkinElmer).
Instrument efficiency was 40%. Protein concentration in the
samples was measured with the Bradford assay using the Sigma-
Aldrich Bradford Reagent. Data are expressed in picomoles of
substrate per milligram of protein (pmol/mg).
PLASMIDS
CMV-hEAAT1 and CMV-hEAAT2 plasmids were prepared in
Susan Amara lab and ordered from Addgene (non-profit orga-
nization for sharing of plasmids, Cambridge, MA, USA; see
Addgene plasmids 32813 and 32814, respectively, for detailed
information and sequences).
HeLa CELL CULTURE AND TRANSIENT TRANSFECTION
Cell culture plasticware was obtained from Nunc. Culture
medium was purchased from Sigma-Aldrich and media supple-
ments were obtained from Invitrogen. HeLa cells were maintained
at 37◦C and 5% CO2 in Dulbecco’s Modified Eagle Medium
(DMEM) containing 10% fetal bovine serum, 100U/ml peni-
cillin, and 100µg/ml streptomycin. For transient transfection,
cells were plated on 6-well plates at a density of 4 × 105 cells
per well. Transfection by CMV-hEAAT1 and CMV-hEAAT2 plas-
mids was performed on the day following the plating in serum-
and antibiotic-free DMEM using the FuGENE HD transfection
reagent (Promega, USA) according to the manufacturer’s instruc-
tions. Each well contained 2µg DNA and 7µl FuGENEHD. Cells
were incubated for 4 h at 37◦C and 5% CO2, then the medium
was replaced with DMEM containing serum and antibiotics.
UPTAKE ASSAY IN TRANSFECTED HeLa CELLS
Aspartate uptake was investigated on the day following trans-
fection using a previously described method (Velaz-Faircloth
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et al., 1996) with modifications. Untransfected HeLa cells
were used as a control. All steps were performed in room
temperature unless otherwise specified. Cells growing on 6-well
plates were washed once with warm uptake buffer and then
pre-incubated in 1ml/well of uptake buffer for 15min at 37◦C
and 5% CO2. The uptake buffer contained (in mM): 120 NaCl,
4.7 KCl, 1.2 KH2PO4, 2 CaCl2, 1.2 MgCl2, 10 D-glucose, 5
Tris-HCl, and 10 HEPES, and the pH was adjusted to 7.40
with NaOH. Subsequently, uptake was initiated by replacing
the pre-incubation buffer with 1ml/well of uptake buffer con-
taining the substrate [20µM D-aspartic acid (Sigma-Aldrich),
1% of which was D-[2,3-3H]-aspartic acid (PerkinElmer;
10.0 Ci/mmol)] either alone or in combination with 1µM
of BaCl2 (Sigma-Aldrich) or 2µM of the EAAT1/2 inhibitor
(3S)-[[3-[[4-(trifluoromethyl)benzoyl]amino]phenyl]methoxy]-
L-aspartic acid (TFB-TBOA). Uptake was continued for 20min
at 37◦C and 5% CO2 and then terminated by placing the cells on
ice and washing rapidly three times with ice-cold 0.32M sucrose.
The cells were then immediately solubilized in 0.25M NaOH
(1ml/well). Radioactivity of the solubilized samples was deter-
mined by scintillation counting using a Wallac WinSpectral 1414
liquid scintillation counter after addition of Optiphase HiSafe 3
scintillation cocktail (PerkinElmer). Instrument efficiency was
40%. Protein concentration in the samples was measured with
the Bradford assay using the Sigma-Aldrich Bradford Reagent.
The data are expressed in picomoles of substrate per milligram of
protein.
CENTROID CALCULATION
This method was previously proposed as a way to estimate the
uptake efficiency: when the efficiency increases, the centroid of
the transporter current becomes smaller because of the faster rise
and decay times of the current (Diamond, 2005). Briefly, the cen-
troid was calculated as the ratio of the first moment of the TC






The time frame was confined to the duration of TC waveform.
Each data point was multiplied by its corresponding time point.
The resulted waveform was integrated and divided by the integral
of TC waveform.
STATISTICAL ANALYSIS
Averaged data are presented as mean ± standard error of mean
(SEM). Statistical significance was assessed using, Student’s t-test
or One-Way ANOVA with post-hoc Tukey test, as indicated in
the figure legends or in the text. A P-value of less than 0.05 was
considered statistically significant.
RESULTS
Whole-cell voltage-clamp recordings of transporter currents were
performed in visually identified astrocytes in rat hippocampal
slices. A subset of the recorded cells was filled with biocytin
through the recording pipette, and post-hoc reconstruction of
the cells revealed typical astrocytic morphology and staining of
neighboring astrocytes due to biocytin diffusion through the gap-
junctions (Figure 1A). Recorded cells had a relatively large hyper-
polarized resting membrane potential (−81.4 ± 0.6mV, n = 62,
measured in current clamp mode), low membrane resistance
(23 ± 2M, n = 62), and linear I-V relationship (Figure 1B).
Electrical stimulation of the Schaffer collaterals elicited a
biphasic inward current with fast and slow components in
astrocytes voltage-clamped at −80mV. Glutamate transporters
mediated the fast current component, because the current was
fully blocked by a mixture of transporter blockers compris-
ing 100µM TBOA, 50µM dihydrokainate, and 100µM threo-
hydroxy-aspartate (Figure 1C). We assumed that the slow current
component was mediated by Kir (Kofuji and Newman, 2004) and
would be sensitive to Ba2+. Therefore, to isolate the glutamate
transporter current, Ba2+ was added to the bath at the same
concentration (200µM) as previously described (D’Ambrosio
et al., 2002; De Saint Jan and Westbrook, 2005). Along with
the expected K+ current blockade, Ba2+ strongly increased the
amplitude of the transporter current (thereafter also referred to
as “potentiation of the transporter current”; Figure 1D). A sim-
ilar increase in transporter current was previously reported in
response to a cocktail of K+ channel blockers (including Ba2+)
and attributed to decrease in membrane conductance (Ge and
Duan, 2007). Indeed, Kir blockade increased input resistance (Ri,
24 ± 2M in control and 31± 3M in Ba2+, n = 16, P = 0.002
for difference, paired t-test), potentiation of the transporter cur-
rent could be explained by increase in the membrane length
constant, which is proportional to the square root of Ri. In this
case, a higher membrane time constant would lead to a larger
contribution of transporter currents originating in distant astro-
cytic processes into the current recorded in the soma, and the
time-courses of the effects of Ba2+ on transporter current and
on membrane conductance would correlate. We found, however,
that augmentation of transporter current started earlier than the
change in K+ current and in holding current at the beginning
of Ba2+ application (Figure 2). Moreover, the transporter current
augmentation persisted longer upon Ba2+ washout (transporter
current in BaCl2: 400 ± 99% of control, n = 5; 5min washout:
411 ± 86% of control, n = 5, One-Way ANOVA, F(2, 12) = 5.42,
P = 0.021; post-hoc Tukey test, P = 0.587 for difference between
BaCl2 and washout; Figure 2B) than did suppression of the
K+ current (K+ current in BaCl2: 44 ± 10% of control, n = 5;
5min washout: 175 ± 40% of control, n = 5, One-Way ANOVA,
F(2, 12) = 10.71, P = 0.002; post-hoc Tukey test, P = 0.002 for
difference between BaCl2 and washout; Figure 2C) and holding
current (Ihold in BaCl2: 347 ± 61 pA, n = 5; and 84 ± 51 pA
at 5min of washout, n = 5, One-Way ANOVA, F(2, 12) = 23.83,
P < 0.001; post-hoc Tukey test, P < 0.001 for difference between
BaCl2 and washout; Figure 2D), suggesting that the change in the
membrane conductance did not contribute to the effect of Ba2+
on the transporter current.
Because the Ba2+ concentration gradually increases in the tis-
sue after adding the drug to the perfusion system, the faster
effect on transporter current suggests its higher sensitivity to Ba2+
than K+ current. One possibility is that low Ba2+ concentrations
increased presynaptic glutamate release, leading to a larger trans-
porter current. To test this we replaced synaptic stimulation with
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FIGURE 1 | Recordings from “passive” astrocytes reveal sensitivity of
glutamate transporter current to Ba2+. (A) Astrocytes in hippocampal
CA1 stratum radiatum (stained with biocytin) s.p.—stratum pyramidale.
Arrow indicates a patched astrocyte. (B) I-V relation of the patched
astrocyte. Inset: membrane currents in response to voltage steps. (C)
Astrocytic current induced by electrical stimulation of Schaffer collaterals
in control and in the presence of glutamate transporter current blockers
(TCB). Gray trace—“pure” transporter current obtained by subtracting
the current in TCB from the control current. (D) Ba2+ (200µM)
abolishes the slow K+ component of the complex current and
increases the amplitude of fast transporter current, which is
consequently blocked by TCB (Ba2+ + TCB).
FIGURE 2 | Time-course of Ba2+ effect on transporter current and
K+ current. (A) Bath-applied 200µM BaCl2 produces downward shift in
Ihold (black triangles), and increase in transporter current (TC, empty
circles) in a single cell. (B) Summary graph of mean normalized
transporter current (TC, n = 5) in the presence of Ba2+ and after 5min
of washout (wash). (C) Summary graph of normalized K+ current
(n = 5) in the presence of Ba2+ and after 10min of washout (wash) (D)
Summary graph of mean Ihold (n = 5) in the presence of Ba2+ and
after 10min of washout (wash). Error bars—SEM; ∗∗P < 0.01; N.S.—non
significant; One-Way ANOVA post-hoc Tukey test.
local glutamate uncaging. Because no action potential or synap-
tic activation was involved, a K+ current did not accompany
the transporter current in this case. We plotted dose-response
curves for the effect of Ba2+ on the transporter current andIhold
(Figure 3A). Consistent with the synaptic stimulation results,
the half-maximal effective concentration (EC50) for the trans-
porter current was 13µM, while EC50 for Ihold was 183µM.
Strikingly, lowmicromolar Ba2+ concentrations (1-50µM) effec-
tively increased the transporter current, but had no detectable
effect on the holding current. This finding suggests that the Ba2+-
induced potentiation of transporter current was not mediated by
its effect on presynaptic glutamate release.
Although the EC50 for the transporter current and for the
holding current differed, there is a possibility that Ba2+ affected
K+ conductance in distal processes which cannot be detected with
somatic recordings. Activation of the transporters during synaptic
stimulation may indeed occur at such distal astrocytic processes.
This possibility can be ruled out by the result of uncaging exper-
iments, because the glutamate uncaging spot was located at the
soma, right at the place where the holding current and transporter
current were occurred in this case.We then further tested the con-
tribution of the membrane conductance change to the effect of
Ba2+ on the transporter current by blocking K+ channels from
inside the cell with Cs+ (Janigro et al., 1997; Tang et al., 2009).
Although Cs+ blocks K+ channels, it can substitute for K+ at the
counter-transport site of glutamate transporters (Barbour et al.,
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FIGURE 3 | Potentiation of transporter current is independent of Kir
blockade. (A) Dose-response curve of TC (circles) and Ihold (triangles)
changes. (B) Transporter current (TC) elicited by local glutamate uncaging in
control and in 200µM Ba2+. The downward shift in the holding current was
less pronounced in Cs+-loaded cells (CsCl). The TC amplitude increased to
a similar degree in both cases. (C,D) Mean Ba2+ effect on transporter
current (TC, B) and Ihold (Ihold, C) for CsCl- and KCl-based intracellular
solutions. (E) Transporter current centroids in control and in 20µM Ba2+.
Error bars—SEM. ∗P < 0.05; N.S.—non significant; paired (E) and unpaired
(C,D) t-test.
1991). We compared the effect of Ba2+ on the holding current
and transporter current induced by local glutamate uncaging in
astrocytes recorded with K+-based and Cs+-based intracellular
solutions (Figure 3B). Ba2+ at 500µM potentiated the trans-
porter current in Cs +-loaded astrocytes to the same extent as
in astrocytes recorded with the K+-based intrapipette solution
(transporter current increased to 223 ± 21% of control with Cs+
solution, n = 6; and to 200 ± 9% of control with K+ solution,
n = 5; P = 0.66, unpaired t-test; Figure 3C). In contrast, the
effects of Ba2+ on the holding current were significantly lower
in cells recorded with Cs+ (change in holding current, Ihold:
−103 ± 86 pA, n = 6, with Cs+ solution; and−303 ± 59 pA, n =
5 with K+ solution; P = 0.02, unpaired t-test; Figure 3D).
Next we measured the centroid of the transporter current
under baseline conditions and in the presence of different con-
centrations of Ba2+ (Figure 3E). This method was previously
proposed as a way to estimate the uptake efficiency: when
the efficiency increases, the centroid of the transporter current
becomes smaller because of the faster rise and decay times of
the current (Diamond, 2005). Here, we also detected a Ba2+-
mediated decrease in the centroid of the uncaging-induced
transporter current (from 47 ± 4ms at control to 37 ± 2ms
in 20µM Ba2+, n = 11, P = 0.002 paired t-test). This sug-
gests that potentiation of transporter current may be associated
with potentiation of glutamate uptake. To test this directly we
studied the Ba2+ effect on uptake efficiency in cultured astro-
cytes. However, 1µM Ba2+ did not significantly increase aspar-
tate uptake (control: 6938 ± 797 pmol/mg, n = 12; Ba2+: 7324 ±
758 pmol/mg, n = 9; P = 0.37, unpaired t-test; Figure 4A). In
cells that were transfected with the CMV-hEAAT1 or CMV–
hEAAT2 plasmids, the aspartate uptake was practically abol-
ished by 2µM TFB-TBOA in the case of both transporters
EAAT1 and EAAT2 expressed in HeLa cells (heterologous sys-
tem, Figures 4B,C). The aspartate uptake was almost fully sup-
pressed by 2µMTFB-TBOA in case of both transporters (EAAT1
control uptake efficiency: 4881 ± 647 pmol/mg, n = 6; vs. TFB-
TBOA: 115 ± 8 pmol/mg, n = 4; P < 0.001, unpaired t-test;
EAAT2 control uptake efficiency: 6085 ± 508 pmol/mg, n = 4;
vs. TFB-TBOA: 107 ± 13 pmol/mg, n = 4; P < 0.001, unpaired
t-test), suggesting that the transporters were indeed expressed
in these cells. Cells that were not transfected retained only a
very small amount of aspartate, comparable to transfected cells
treated with TFB-TBOA (data not shown). Consistent with the
astrocyte results the uptake was not significantly affected by
1µM Ba2+ in either type of HeLa cell (EAAT1 Ba2+: 5120 ±
1205 pmol/mg; P = 0.86 for difference with the control, unpaired
t-test; EAAT2 Ba2+: 5862 ± 1137 pmol/mg; P = 0.86 for differ-
ence with the control, unpaired t-test). These findings suggest
that although Ba2+ increases the amplitude of the glutamate
transporter currents and changes their kinetics at concentra-
tion which do not affect Kir, it does not potentiates glutamate
uptake.
DISCUSSION
The main finding of the present study is the potentiating effect
of low micromolar Ba2+ on astrocytic transporter current which
is not associated with increased glutamate uptake. These Ba2+
concentrations do not change membrane conductance which
could explain the potentiation. Moreover Ba2+ decreases the
transporter current centroid which was used to estimate the effi-
ciency of glutamate uptake (Diamond, 2005; Scimemi et al., 2009;
Thomas et al., 2011). This discrepancy suggests that the difference
in transporter current kinetics may not be due to differences in
glutamate uptake. Therefore additional evidence such as activa-
tion of extrasynaptic receptors (e.g., NMDA receptors) is required
to supplement the transporter current measurements (Scimemi
et al., 2009; Thomas et al., 2011; Tanaka et al., 2013).
Although we find that Ba2+ potentiates the transporter cur-
rent in hippocampal astrocyte the molecular mechanism of this
action is unclear. Indeed, blockade of Kir with Ba2+ produced
a downward shift in the holding current recorded in hippocam-
pal astrocytes, which is consistent with membrane depolarization.
In principle, depolarization in poorly voltage-clamped astrocytic
processes should reduce the efficiency of electrogenic glutamate
transporters. To the contrary, we detected a significant increase in
glutamate transporter currents induced either by synaptic stimu-
lation or by local glutamate uncaging. Potentiation of uncaging-
mediated transporter current suggests that this phenomenon is
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FIGURE 4 | 1µM Ba2+ does not potentiate aspartate uptake by
cultured astrocytes or by HeLa cells expressing glutamate
transporters. (A) Summary graph of aspartate uptake by cultured
astrocytes in control conditions (Ctrl) or in the presence of 1µM BaCl2
(Ba2+). (B) Summary graph of aspartate uptake by HeLa cells expressing
EAAT1 in control conditions (Ctrl), in the presence of 2µM TFB-TBOA, or
in the presence of 1µM BaCl2 (Ba2+). (C) Summary graph of aspartate
uptake by HeLa cells expressing EAAT2 in control conditions (Ctrl), in the
presence of 2µM TFB-TBOA, or in the presence of 1µM BaCl2 (Ba2+).
Error bars—SEM. ∗∗P < 0.01; N.S.—non significant; unpaired t-test.
independent of the effects of Ba2+ on presynaptic release prob-
ability. However, we cannot exclude that a part of potentiation
in the case of synaptically released glutamate can be explained
by presynaptic effects of Ba2+, which were not tested in this
study. Importantly, a significant effect on transporter current
was observed at low micromolar Ba2+ concentrations that pro-
duced no measurable effect on the holding current. Thus, Ba2+
increased the amplitude of glutamate transporter current inde-
pendently of Kir blockade. It is possible that Ba2+ modulated
transporter currents uncoupled from glutamate uptake (Bergles
et al., 2002).
Although our data suggest that Ba2+ acts to increase the
amplitude of glutamate transporter current, the mechanism for
its action remains unclear. Here we tested the effect of Ba2+
on synaptically induced transporter currents and transporter
currents mediated by glutamate uncaging. Although glutamate
uncaging is a useful method it cannot entirely mimic synap-
tically released glutamate. For example, to achieve measurable
transporter current from single uncaging spot we located the
spot at the soma and used 10ms uncaging duration. This is in
contrast to synaptic glutamate release that occurs not only at
synapses close to the soma but also at synapses close to the dis-
tal astrocytic processes and lasts<1ms at each synapse. Moreover,
recent reports suggest existence of Ca2+ microdomains associated
with fragments of astrocytic processes seen in a single imag-
ing plane that are quite distinct from somatic Ca2+ signaling
(Shigetomi et al., 2013; Tong et al., 2013). It is also likely that
properties of glutamate uptake differ between astrocytic soma and
processes. Thus, future studies are needed to identify the mecha-
nism by which Ba2+ exerts its action on transporter current. An
understanding of the mechanism might have important impli-
cations for both research and the development of neuroactive
drugs.
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